Get started
ATARA BIOTHERAPEUTICS INCATARA BIOTHERAPEUTICS INCATARA BIOTHERAPEUTICS INC

ATARA BIOTHERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast

AT2 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪45.04 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.96EUR
Net income (FY)
‪−250.17 M‬EUR
Revenue (FY)
‪7.77 M‬EUR
Shares float
‪98.52 M‬
Beta (1Y)
3.07

About Atara Biotherapeutics, Inc.

Sector
Health Technology
CEO
Pascal Touchon
Headquarters
Thousand Oaks
Website
atarabio.com
Employees (FY)
225
Founded
2012
FIGI
BBG007GFHPW4
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AT2 is 0.38 EUR — it has increased by 0.05% in the past 24 hours. Watch ATARA BIOTHERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ATARA BIOTHERAPEUTICS INC stocks are traded under the ticker AT2.
AT2 stock has fallen by 21.16% compared to the previous week, the month change is a 32.85% fall, over the last year ATARA BIOTHERAPEUTICS INC has showed a 79.52% decrease.
We've gathered analysts' opinions on ATARA BIOTHERAPEUTICS INC future price: according to them, AT2 price has a max estimate of 301.78 EUR and a min estimate of 11.61 EUR. Watch AT2 chart and read a more detailed ATARA BIOTHERAPEUTICS INC stock forecast: see what analysts think of ATARA BIOTHERAPEUTICS INC and suggest that you do with its stocks.
AT2 reached its all-time high on Apr 23, 2015 with the price of 60.94 EUR, and its all-time low was 0.20 EUR and was reached on Nov 13, 2023. View more price dynamics on AT2 chart.
See other stocks reaching their highest and lowest prices.
AT2 stock is 13.62% volatile and has beta coefficient of 3.07. Track ATARA BIOTHERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is ATARA BIOTHERAPEUTICS INC there?
Today ATARA BIOTHERAPEUTICS INC has the market capitalization of ‪45.03 M‬, it has increased by 0.33% over the last week.
Yes, you can track ATARA BIOTHERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
ATARA BIOTHERAPEUTICS INC is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
AT2 earnings for the last quarter are −5.33 EUR per share, whereas the estimation was −5.95 EUR resulting in a 10.39% surprise. The estimated earnings for the next quarter are −2.00 EUR per share. See more details about ATARA BIOTHERAPEUTICS INC earnings.
ATARA BIOTHERAPEUTICS INC revenue for the last quarter amounts to ‪25.35 M‬ EUR, despite the estimated figure of ‪22.88 M‬ EUR. In the next quarter, revenue is expected to reach ‪34.52 M‬ EUR.
AT2 net income for the last quarter is ‪−29.43 M‬ EUR, while the quarter before that showed ‪−54.77 M‬ EUR of net income which accounts for 46.27% change. Track more ATARA BIOTHERAPEUTICS INC financial stats to get the full picture.
No, AT2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 20, 2024, the company has 225.00 employees. See our rating of the largest employees — is ATARA BIOTHERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATARA BIOTHERAPEUTICS INC EBITDA is ‪−197.26 M‬ EUR, and current EBITDA margin is ‪−3.08 K‬%. See more stats in ATARA BIOTHERAPEUTICS INC financial statements.
Like other stocks, AT2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATARA BIOTHERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATARA BIOTHERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATARA BIOTHERAPEUTICS INC stock shows the sell signal. See more of ATARA BIOTHERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.